Jerry has worked 28 plus years in the pharmaceutical industry - 18.5 years Bristol-Myers Squibb, 2 years Pharmacia/UpJohn/Pfizer, 7+ years for Merck/Serono
His background includes Pre-med, Organic, In-organic,and Biochemistry, Microbiology. He is a published author with an article in Organic Chemistry. He is a graduate of Montana State University, Bozeman, MT
Attention: The statements made on this web site have not been evaluated by the Food and Drug Administration (FDA). The products featured are not intended to diagnose, treat, cure or prevent any disease. Any medical concerns should be directed to a qualified health consultant.
Drug Safety and Availability FDA Drug Safety Communication: 5-alpha reductase inhibitors (5-ARIs) may increase the risk of a more serious form of prostate cancer
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.